ClinicalTrials.gg
RecruitingNCT06209918Updated Jan 18, 2024

Effect of Bioptron Light on Carpal Tunnel Syndrome(BLCTS)

An interventional study of bioptron light therapy and wrist brace in Carpal Tunnel Syndrome Pregnancy, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to female participants aged 25 Years to 35 Years. Per ClinicalTrials.gov, last updated 2024-01-18.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Jul 2023; still recruiting 3 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
25 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Carpal Tunnel Syndrome by Cairo University — 9 open to participants now, 10 under way, none of them phase 3. Carpal Tunnel Syndrome · Cairo University.

Planned enrollment
4th of 20
62 · median 55
Started
2023
with 7 others
No phase
19 of 21
9 open now
Registered
10th of 21
by date

Among the 21 studies in Carpal Tunnel Syndrome by Cairo University, this one is the 4th largest by planned enrollment of the 20 interventional ones that give a count, is one of 8 that started in 2023, is one of 19 with no phase, and was the 10th registered.

Carpal Tunnel Syndrome

591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

9 of the 21 studies in Carpal Tunnel Syndrome by Cairo University are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 25 Years to 35 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Carpal Tunnel Syndrome by Cairo University, or all of them as a file.
02

Study summary

The purpose of this study is to investigate the effect of bioptron light therapy on pregnancy related carpal tunnel syndrome

Read the detailed description

Carpal tunnel syndrome (CTS) is a symptomatic compression neuropathy of the median nerve at the level of the wrist, characterized by hand pain, numbness, and tingling in the distribution of the median nerve (thumb, index, middle finger, and the radial side of the ring finger) and a reduction in grip strength and hand function. The severity of symptoms can be clinically categorized into mild, moderate, and severe Bioptron phototherapy acts as a "sterile" trigger on human in vitro isolated peripheral blood mononuclear cells (PBMCs), affecting their cytokine production and driving the immune response towards an anti-inflammatory/reparative profile and representing a non-pharmaceutical and non-invasive option for several clinical conditionsA randomized control study, the women will be randomly assigned into two groups, (31 women for each group) equal in number. Group (A) will include 31 women will receive Bioptron light combined with advice and patient education (10 minutes per session, 3 sessions per week, for 4 weeks). Group (B) will be receiving advice only for same duration as group (A)

03

Conditions studied

  • Carpal Tunnel Syndrome Pregnancy

Keywords

  • Bioptron light therapy
  • Phototherapy
  • Carpal tunnel syndrome
04

Who can participate

Ages eligible
25 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant females clinically daignosed with carpal tunnel syndrome at least 1 month
  • age will range from (25-35) years.
  • (BMI) will be (BMI ≤ 35 kg/m2)

Exclusion criteria

Exclusion Criteria:

  • history of neurologic disease
  • hand surgery
  • hand trauma,
  • diabetes mellitus
  • cervical spondylosis
  • osteoarthritis of cervical spine and wrist joint
  • chronic renal failure
  • heart failure
  • connective tissue disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    group that recieve bioptron light and advice and patient education

    patients will recieve bioptron light therapy for 10 minutes per session, 3 sessions per week, for 4 weeks.

    Device: bioptron light therapy

  • Other
    control group that recieve advice and patient education and wrist brace

    will keep the wrist in a neutral position, not bent back or bent down too far

    Device: wrist brace

Interventions

  • Devicebioptron light therapy

    patient will be sitting on comfortable chair with the hand placed on an armrest in an extended and supinated position. Firstly, the skin over the wrist area will be exposed and cleaned by alcohol to achieve maximal penetration of light. Then, the bioptron device will be held perpendicular to the surface of the treated area, at a distance of 10 cm.

  • Devicewrist brace

    will keep the wrist in a neutral position, not bent back or bent down too far

06

What researchers measure

Primary outcomes

  1. Nerve conduction studies (NCS)

    assess sensory and motor nerve conduction velocity,gf and sensory nerve action potential

    Time frame: 4 weeks

Secondary outcomes

  1. Visual analogue scale

    assess pain intensity

    Time frame: 4 weeks

Other outcomes

  1. Boston carpal tunnel questionnaire

    Assess Symptom severity and functional capacity

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Sara Magdy Ahmed
    Giza, Egypt
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2023 (actual). Primary completion is estimated for Jul 2024, 12 months after the start.

Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 12 months is close to that.

Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2023
First posted
Jan 18, 2024
StartActual
Jul 1, 2023
Primary completionEst.
Jul 1, 2024
CompletionEst.
Dec 2024
Last update
Jan 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06209918
Lead sponsor
Cairo University
Responsible party
Sara Magdy Ahmed (principal investigator, Cairo University) — Principal investigator
First posted
Jan 18, 2024
Start date
Jul 1, 2023
Primary completion
Jul 1, 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Jan 18, 2024

Study contacts

Sara Ma Ahmed, lecturer
Contact
saramagdy87@cu.edu.eg
01063998331
Sara Ma Ahmed, lecturer
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion